Gates Foundation to spend $120 million to speed access to generics of Merck COVID-19 pill
Go back to Gates Foundation to spend $120 million to speed access to generics of Merck COVID-19 pill| Merck & Co. (NYSE: MRK) | Delayed: 144.91 +1.12 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.79 | 52 Week High | $65.46 | |||
| Open | $143.96 | 52 Week Low | $47.97 | |||
| Day High | $144.97 | P/E | 98.58 | |||
| Day Low | $143.50 | EPS | $1.47 | |||
| Volume | 7,230,591 | |||||
